If you need more lookups,
subscriptions start at $34 USD/month.
Kenneth Koblan Location
Boston, MA, US
Kenneth Koblan Work
2026 -now Chief Scientific Officer @
2024 -2026 Head of Research And Development @
2023 -2024 Head Development Operations @ Dainippon Sumitomo Pharma, Inc.
2019 -2023 Chief Scientific Officer @
2011 -2023 Global Head TMED-Translational Medicine and Early Development Head Discovery Sciences @
2010 -2011 Chief Scientific Officer, Vice President @
2007 -2009 Vice President and Site Head Rahway Basic Research @
2004 -2007 Vice President and Site Head West Point Human Health @
2003 -2004 Executive Director and Dept. Chair @
2001 -2003 Senior Director and Dept. Chair @
1998 -2001 Director, Molecular Pharmacology @
1996 -1998 Associate Director, Dept. of Cancer Research @
1994 -1996 Research Fellow, Dept. of Cancer Research @
1991 -1994 Senior Research Biochemist, Dept. of Cancer Research @
Kenneth Koblan Education
The Johns Hopkins University
Ph. D. (Biochemistry)
1986-1991
Massachusetts Institute of Technology
Bachelor of Science (Biology, General)
1982-1986
Kenneth Koblan Summary
Kenneth Koblan, based in Boston, MA, US, is currently a Chief Scientific Officer at Slate Medicines. Kenneth Koblan brings experience from previous roles at Vesalius Therapeutics, Dainippon Sumitomo Pharma, Inc. and Sunovion Pharmaceuticals. Kenneth Koblan holds a 1986 - 1991 Ph. D. in Biochemistry @ The Johns Hopkins University. Kenneth Koblan has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Kenneth Koblan?
Find contact details for 700 million professionals.